These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Myocardial infarct--seizure--psychosis. The drug emergency has many faces]. Bischoff A. MMW Fortschr Med; 2000 Mar 30; 142(13):19. PubMed ID: 10783617 [No Abstract] [Full Text] [Related]
26. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder. McCormick B, Blum N, Hansel R, Franklin JA, St John D, Pfohl B, Allen J, Black DW. Compr Psychiatry; 2007 Mar 30; 48(5):406-12. PubMed ID: 17707247 [Abstract] [Full Text] [Related]
28. Assessment of public health and social problems associated with the use of psychotropic drugs. Report of the WHO Expert Committee on Implementation of the Convention on Psychotropic Substances, 1971. World Health Organ Tech Rep Ser; 1981 Mar 30; 656():1-54. PubMed ID: 6782764 [No Abstract] [Full Text] [Related]
29. Psychoses and illicit drug use: need for cross-cultural studies. Thirthalli J, Venkatesh BK, Gangadhar BN. Acta Psychiatr Scand; 2008 Jul 30; 118(1):86; author reply 86-7. PubMed ID: 18489616 [No Abstract] [Full Text] [Related]
30. Schizophrenia and comorbid substance use disorder: effects of antipsychotics. Green AI. J Clin Psychiatry; 2005 Jul 30; 66 Suppl 6():21-6. PubMed ID: 16107180 [Abstract] [Full Text] [Related]
31. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients]. Lambert M, Haasen C, Mass R, Krausz M. Psychiatr Prax; 1997 Jul 30; 24(4):185-9. PubMed ID: 9340658 [Abstract] [Full Text] [Related]
32. Cognitive efficiency in alcoholics and polysubstance abusers. Nixon SJ, Paul R, Phillips M. Alcohol Clin Exp Res; 1998 Oct 30; 22(7):1414-20. PubMed ID: 9802522 [Abstract] [Full Text] [Related]
33. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA. J Nerv Ment Dis; 2006 Mar 30; 194(3):164-72. PubMed ID: 16534433 [Abstract] [Full Text] [Related]
34. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries. Fals-Stewart W. J Subst Abuse; 1996 Mar 30; 8(1):1-17. PubMed ID: 8743765 [Abstract] [Full Text] [Related]
35. How does one manage a patient with an anxiety disorder who has been self-medicating with psychotropic drugs? Wilson A. J Psychiatry Neurosci; 1999 Nov 30; 24(5):483. PubMed ID: 11499430 [No Abstract] [Full Text] [Related]